MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas

CONCLUSION: MCM10 is an independent prognostic index of glioma patients, and the high expression of MCM10 suggests a poor prognosis; MCM10 expression is closely related to the immune cell infiltration of gliomas, and MCM10 may be related to drug resistance and development of gliomas.PMID:36872806 | DOI:10.3233/THC-220576
Source: Technology and Health Care - Category: Medical Devices Authors: Source Type: research